As tumor immunosuppression is a critical step of preinvasive-to-invasive transition and relates to poor prognoses in BC [38], we speculate that the prognostic role of ARL11 in BC may be due to its function in boosting tumor immunosuppression. This evidence concerns the gene ARL11 and neoplasm.